Previous studies discovered that over-expression of BUB1B in tumor tissues predicts a poor prognosis of pancreatic ductal adenocarcinoma and adrenal carcinoma, while the low expression of BUB1B is associated with poor survival in patients with colon adenocarcinoma and lung cancer [26]. Here, BUB1B is linked to pancreatic ductal adenocarcinoma.